000052519 000__ 01129cam\a2200253W1\4500
000052519 001__ 52519
000052519 005__ 20220217103624.0
000052519 008__ 820901s1982\\\\dcua\\\\b\\\\f00010\eng\d
000052519 035__ $$a(OCoLC)ocm08738444
000052519 035__ $$a00056973
000052519 035__ $$9AAF4037SI
000052519 035__ $$a52519
000052519 040__ $$aEZF$$cEZF$$dISE
000052519 049__ $$a[Microfiche]ISED
000052519 099__ $$aY4.G 74/7 :D63/4
000052519 099__ $$aY4.G$$a74/7$$a:D63/4
000052519 1101_ $$aUnited States.$$bCongress.$$bSenate.$$bCommittee on Government Operations.$$bIntergovernmental Relations and Human Resources Subcommittee.
000052519 24514 $$aThe end stage renal disease program :$$bhearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session.
000052519 260__ $$aWashington :$$bU.S. G.P.O.,$$c1982-
000052519 300__ $$av. :$$bill. ;$$c24 cm.
000052519 61010 $$aUnited States.$$bMedicare Bureau.$$bEnd-Stage Renal Disease Program.
000052519 650_0 $$aChronic renal failure$$xGovernment policy$$zUnited States.
000052519 85231 $$bdfich$$hY 4.G 74/7$$i:D 63/4/
000052519 909CO $$ooai:library.usi.edu:52519$$pGLOBAL_SET
000052519 966__ $$c 1$$lUSIGEN$$mMFICHE$$sY4.G 74/7 :D63/4/$$dpt.2$$xISED$$z099$$b39203009851846
000052519 966__ $$c 1$$lUSIGEN$$mMFICHE$$sY4.G 74/7 :D63/4/$$dpt.1$$xISED$$z099$$b39203009851838
000052519 980__ $$aBIB
000052519 980__ $$aGOV RESOURCE